Furthermore, in the realm of molecular biomarkers, high expression of proteins such as p53, CD133, phosphorylated AKT, and CUG‐binding protein (CUGBP1) has been closely linked to recurrence in stage IB NSCLC [22, 23, 24, 25], positioning them as potential indicators of recurrence risk. Here, TP53 is linked to non-small cell lung carcinoma.